Enzalutamide trials for Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Q: How many trials study Enzalutamide for Metastatic Castration-Resistant Prostate Cancer (mCRPC)?

3 recruiting trials study Enzalutamide in trials listing Metastatic Castration-Resistant Prostate Cancer (mCRPC) in our tracked data. This is not a statement that it treats the condition.

All Enzalutamide trials · All Metastatic Castration-Resistant Prostate Cancer (mCRPC) trials

Recruiting trials

Phase breakdown

Phase 1 2Phase 3 1

Recruiting trials studying Enzalutamide for Metastatic Castration-Resistant Prostate Cancer (mCRPC)

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
NCT03460977 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 84 locations
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
NCT06136650 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 330 locations
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
NCT07570979 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 3 locations

Common questions

How many trials study Enzalutamide for Metastatic Castration-Resistant Prostate Cancer (mCRPC)?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.